- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
130 Cards in this Set
- Front
- Back
|
What proportion of insulin is released as a basal amount and as a bolus amount?
|
50/50
|
|
How long does an insulin bolus typically last?
|
2 hours
|
|
What is the amount of basal insulin released?
|
1 unit of insulin/hr regardless of food intake
|
|
How does bolus insulin act?
|
Limits postprandial hyperglycemia by stimulating glucose uptake by peripheral tissue; released in response to food
|
|
How is insulin secreted?
|
1. Glucose enters beta cells via Glut-2
2. K+ channels are blocked, causing membrane depolarization and opens Ca2+ channels 3. Ca2+ signal induces insulin secretion |
|
What is diabetes mellitus?
|
Syndrome that develops when insulin secretion or activity are not sufficient to maintain normal blood glucose levels
|
|
How do Type 1 and Type 2 DM compare?
|
Type 1 results from beta cell destruction --> ABSOLUTE lack of insulin
Type 2 results from progressive insulin secretory defect and insulin resistance --> RELATIVE lack of insulin |
|
What are some acute complications of DM?
|
Hypoglycemia; diabetic ketoacidosis (DKA); HHONK
|
|
What are some chronic complications of DM?
|
1. Microvascular -- retinopathy, nephropathy, neuropathy
2. Macrovascular -- CV, cerebrovascular, peripheral vascular disease |
|
What are the goals for glycemic control?
|
Hgb A1c of <7.0% (or </= 6.5% with other sources)
|
|
How often should Hgb A1c levels be obtained?
|
Every 6 months for patients at goal
Quarterly for uncontrolled patients |
|
What are non-glycemic goals for patients with DM?
|
1. BP < 130/80
2. LDL < 100 (<70 in CV patients) 3. Triglycerides < 150 |
|
What is the goal for peak postprandial glucose (1-2 hrs after meal)?
|
< 180
|
|
Why can insulin not be administered orally?
|
Peptide hormone -- would be denatured by stomach acid before it could take effect
|
|
In which Type 2 DM patients would insulin be appropriate?
|
1. Patients who cannot control their condition with diet, exercise, and oral meds
2. Newly diagnosed Type 2 presenting with severe, symptomatic hyperglycemia |
|
What are the rapid-acting insulins?
|
insulin lispro, insulin aspart, insulin glulisine
|
|
When should rapid-acting insulin be administered?
|
Immediately before meal (onset: 15-30 min)
|
|
What routes can rapid-acting insulin be administered?
|
subQ and IV
|
|
How does rapid-acting insulin appear?
|
Clear
|
|
What are the short-acting insulins?
|
Regular novolin R, regular humulin R
|
|
When should short-acting insulin be administered?
|
30-45 min before meals (onset: 30 min)
|
|
What routes are possible for short-acting insulin?
|
subQ and IV (shorter duration of action)
|
|
What is the appearance of short-acting insulin?
|
Clear
|
|
What are the intermediate-acting insulins?
|
NPH humulin N, NPH novolin N
|
|
When is intermediate-acting insulin administered?
|
Usually administered once or twice daily (onset: 2-4 hrs); can be used as basal insulin
|
|
What is the appearance of intermediate-acting insulin?
|
Cloudy
|
|
How is intermediate-acting insulin administered?
|
subQ only
|
|
What are the long-acting insulins?
|
Insulin glargine, insulin detemir
|
|
Of the long-acting insulins, which does not have a peak?
|
Insuline glargine (Lantus)
|
|
When should long-acting insulin be administered?
|
Any time of day (depending on patient's eating habits) as long as it is consistently administered
|
|
What is the appearance of long-acting insulins?
|
Clear
|
|
What is the route of administration for long-acting insulins?
|
SubQ only
|
|
How does hepatic or renal failure affect insulin duration of action?
|
Liver disease -- glucose is not produced by liver so a little insulin goes a long way
Renal disease -- excretion is very slow so less insulin is required |
|
How do insulin combination products work?
|
~30% is rapid/short-acting to cover meals
~70% is intermediate/long-acting to provide basal insulin |
|
What are some guidelines for dosing insulin?
|
1. 1 unit of insulin will lower BG by 50-100
2. Start with low dose and titrate up 3. Wait 24 hrs before adjusting dose |
|
How long are vials/pens of insulin valid for at room temperature?
|
28 days
|
|
What are the s/s of hypoglycemia?
|
Sympathetic: tachycardia, palpitations, sweating, and tremulousness
Parasympathetic: nausea and hunger |
|
What is a possible consequence of not rotating injection sites?
|
Lipohypertrophy
|
|
How is hypoglycemia treated?
|
Mild (pt. conscious) -- simple sugar should be administered
Severe (unconscious) -- 20-50 ml of 50% dextrose IV; 1 mg glucagon subQ or IM |
|
What is the MOA of sulfonylureas?
|
Increase secretion of pre-formed insulin by closing K+ channels (cause insulin release whether or not glucose is present)
|
|
What is the secondary effect of sulfonylureas?
|
Increase insulin receptor sensitivity and decrease hepatic glucose output
|
|
What is the #1 complication of sulfonylureas?
|
HYPOglycemia
|
|
Which second gen. sulfonylureas are good for patients with renal dysfunction?
|
1. Glipizide (90% hepatic elimination)
2. glimepiride (100% hepatic elimination) |
|
Why are first gen. sulfonylureas not favorable?
|
High frequency of hypoglycemia and lower potency
|
|
In which patients are sulfonylureas contraindicated?
|
Patients with sulfa allergies
|
|
What are some adverse effects of sulfonylureas?
|
Photosensitivity (wear sunscreen); Abnl liver fxn tests; weight gain
|
|
What is the MOA of meglitinides?
|
Same as sulfonylureas (increase secretion of pre-formed insulin by closing K+ channels)
|
|
How are meglitinides r/t sulfonylureas?
|
structurally similar but w/o sulfa moiety (okay for pts with sulfa allergies)
|
|
What drugs are meglitinides?
|
repaglinide; nateglinide
|
|
What are the potential advantages of meglitinides?
|
1. Rapid onset and short duration of action
2. Okay with renal insufficiency 3. May be okay with pts who skip meals |
|
What are the adverse effects of meglitinides?
|
Hypoglycemia; weight gain
|
|
How are meglitinides metabolized?
|
Liver -- CYP 3A4; caution with drug-drug interactions
|
|
What is the MOA for biguanides?
|
Decrease hepatic glucose output
|
|
What are the secondary effects of biguanides?
|
Increase peripheral glucose uptake and utilization
|
|
What is the name of the medication in the biguanide class?
|
Metformin (glucophage)
|
|
What is the #1 reason for patients d/c biguanides (metformin)
|
GI intolerance (GI upset, lactic acidosis)
|
|
How are biguanides excreted?
|
100% renal
|
|
In which patients are biguandies contraindicated?
|
1. Renal impairment -- M creat >= 1.5; F creat >= 1.4
2. Hepatic impairment -- lactic acid elimination problem 3. Hypoxic states, acute/chronic alcohol abuse, elderly, CHF (on drug therapy) |
|
What are some special considerations for patients using metformin?
|
Patient needs to be well-hydrated when undergoing diagnostic tests with iodinated contrast materials --> kidney dysfxn if dehydrated => metformin not excreted, leading to lactic acidosis
|
|
What are the alpha-glucosidase inhibitors?
|
acarbose; miglitol
|
|
What is the MOA for alpha-glucosidase inhibitors?
|
Potent competitive inhibitor of brush border alpha-glucosidases necessary for the breakdown of complex carbs
|
|
What are the adverse effects of alpha-glucosidase inhibitors?
|
Abdominal pain, flatulence, diarrhea
Acarbose -- increase LFTs at very high doses |
|
In what patients is alpha-glucosidase inhibitor use contraindicated?
|
Significant GI disorders
|
|
What is the therapeutic effect of alpha-glucosidase inhibitors?
|
Delayed breakdown of carbs allows insulin time to be released --> insulin needed (Type 2 DM only)
|
|
What are the thiazolidinediones?
|
Rosiglitazone, pioglitazone
|
|
What is the MOA of thiazolidinediones?
|
Bind to the nuclear steroid hormone receptor and promote glucose uptake into skeletal and muscle/adipose tissue
|
|
What are the effects of thiazolidinediones?
|
1. Decrease insulin resistance
2. Increase insulin sensitivity 3. Do not effect insulin secretion |
|
What are the adverse effects of thiazolidinediones?
|
Hepatotoxicity (LFT q6 mos.); edema (worse when combined with insulin)
|
|
What are the cautions/contraindications of thiazolidinediones?
|
May cause or exacerbate CHF
Contraindicated in patients with Class 3 or 4 heart failure |
|
What are incretins?
|
GI hormones released in response to glucose (GLP-1, GIP); incretins are broken down by DPP-4
|
|
How does GLP-1 act?
|
1. Enhances glucose-dependent insulin secretion
2. Suppression of glucagon secretion 3. Slows the rate of gastric emptying 4. Reduces appetite |
|
Which incretin mimetic functions as a GLP-1 agonist?
|
exenatide (Byetta)
|
|
What are some cautions for exenatide (Byetta)?
|
Not recommended in patietns with CrCl < 30
Use caution when starting or titrating up dose in patients with CrCl of 30-50 Contraindicated in patients with severe GI disorders |
|
What are the adverse effects of exenatide (Byetta)?
|
Hypoglycemia (esp. in combo with sulfonylureas); nausea/diarrhea; headache, pancreatitis
|
|
Which incretin mimetics are DPP-4 inhibitors?
|
sitagliptin, saxagliptin
|
|
What is the therapeutic effect of DPP-4 inhibitors?
|
GLP-1 lasts longer (increased insulin secretion, glucagon suppression, etc.)
|
|
How is exenatide (Byetta) administered?
|
subQ
|
|
How are DPP-4 inhibitors (incretin mimetics) administered?
|
PO
|
|
What are the adverse effects of DPP-4 inhibitors (incretin mimetics)?
|
1. No evidence of hypoglycemia to date
2. Recent cases of pancreatitis with sitagliptin |
|
What drug is an amylin analogue?
|
pramlintide (Symlin)
|
|
What is the MOA of the amylin analogue?
|
1. Slows gastric emptying
2. Suppresses glucagon secretion 3. Decreases glucose output by liver |
|
What is the therapeutic use of amylin analogues?
|
1. Adjunctive therapy with insulin for type 1 DM
2. Type 2 DM |
|
How is the amylin analogue administered?
|
subQ only
|
|
What considerations should be given to amylin analogues?
|
1. Empiric insulin dose reduction necessary
2. Administer prior to meals |
|
What are the adverse effects of amylin analogues?
|
Severe hypoglycemia (perhaps because of combo with insulin therapy); GI disturbances
|
|
In what cases should insulin be used early in Type 2 DM patients?
|
1. Hgb A1c > 10%
2. Random glucose > 300 or fasting glucose > 250 3. Hyperglycemic symptoms 4. Presence of urine ketones |
|
What are the possible causes of HYPERthyroidism?
|
1. Graves disease
2. Thyroid-stimulating antibodies 3. Meds (amiodarone) |
|
What occurs in HYPERthyroidism?
|
1. Elevated total T4 and free T4 serum concentrations
2. Suppressed TSH concentrations (except in TSH-secreting adenomas) |
|
What is the purpose of surgery for HYPERthyroidism?
|
Removal of the thyroid gland once the patient is pharmacologically euthyroid
|
|
What are the most common complications of surgery for HYPERthyroidism?
|
1. Hypothyroidism
2. Hypoparathyroidism 3. Vocal cord abnormalities |
|
What is the MOA of thioureas?
|
Inhibit iodination of tyrosine and the coupling of iodotyrosines
Does not affect release of preformed T4 and T3 (body still has to utilize pre-made TH) |
|
What meds fall into the thioureas?
|
Propylthiouracil (PTU), methimazole
|
|
What additional MOA does PTU have?
|
Inhibits the peripheral conversion of T4 to T3
|
|
How long does it take for thioureas to act?
|
They have short half-lives but accumulate in the thyroid gland to exert longer effects --> patient becomes euthyroid in 1-2 months
|
|
What are the adverse effects of thioureas?
|
Rash; fluid retention; decreased WBC count
If decreased WBC count is not caught and treated early, can lead to long-term immunocompromise |
|
What are the indications for iodine-containing compounds?
|
Used for pre-surgery to prevent active secretion of TH during surgery (MOA is the immediate inhibition of the release of T4 and T3)
Not used for routine tx |
|
What are the names of common iodine-containing compounds?
|
Lugol's solutio, potassium iodide solutions (SSKI)
|
|
What are some adverse effects of iodine-containing compounds?
|
Rash, metallic taste, sore gums, GI discomfort, HYPOthyroidism
|
|
What is the MOA of beta-adrenergic antagonists?
|
1. Decrease symptoms of adrenergic stimulation caused by increased T4 concentrations
2. Inhibit peripheral conversion of T4 to T3 |
|
What is the most commonly used beta-adrenergic antagonist for HYPERthyroidism?
|
Propranolol (non-selective beta blocker)
Any beta blocker will have safe effect though |
|
What are the adverse effects of a beta-adrenergic antagonist?
|
Decreased BP, bradycardia, cardiac arrest, CHF; asthma
|
|
What is the MOA of corticosteroids for HYPERthyroidism?
|
1. Decrease thyroid action
2. Decrease immune response in Grave's disease |
|
How does radioactive iodine work?
|
Concentrates in the thyroid and destroys thyroid tissue
|
|
What may be used as adjunctive therapy until radioactive therapy takes effect?
|
Beta-adrenergic antagonists can be used to control symptoms
|
|
What is an absolute contraindication for radioactive iodine?
|
Pregnancy -- will destroy baby's thyroid gland too
|
|
What are the possible causes of HYPOthyroidism?
|
1. Hashimoto's thyroiditis
2. Surgery 3. Meds (radioactive iodine, lithium, amiodarone) |
|
What are the diagnostic criteria for HYPOthyroidism?
|
1. Decreased total T4 and free serum T4
2. Elevated TSH concentrations 3. Thyroid antibodies |
|
What are the goals of therapy for HYPOthyroidism?
|
1. Restore normal thyroid concentrations in tissue
2. Provide symptomatic relief |
|
What are the natural thyroid hormones?
|
Thyroid -- made from desiccated hog, beef, or sheep thyroid
Thyroglobulin -- purified hog gland extract |
|
Why are natural thyroid hormones less favorable?
|
1. Bioavailability is unpredictable
2. Allergies (animal products) |
|
What synthetic thyroid hormones are available?
|
Levothyroxine, liothyronine, liotrix
|
|
Which synthetic thyroid hormone is the drug of choice and why?
|
Levothyroxine
Advantages: chemically stable, inexpensive, free of antigenicity |
|
Which synthetic thyroid hormone has a higher incidence of cardiac events?
|
Liothyronine -- dysrhythmias
|
|
What special consideration must be paid to levothyroxine?
|
It is a pro-drug so it must be activated in body
--> takes 2-3 weeks to get to steady state of T4 to T3 conversion |
|
What are the adverse effects of levothyroxine?
|
Heart failure, angina, MI; HYPERthyroidism
|
|
What dose adjustments should be made for elderly patients or patients with hx of heart disease taking levothyroxine?
|
Half the dose
|
|
What is the primary action of the hypothalamus-pituitary-adrenal system?
|
Regulate the production of cortisol
|
|
Whats is the peak secretion time of cortisol?
|
0600-0800
|
|
When do MI's often occur?
|
Morning hours because that is when cortisol levels are the highest
|
|
How does negative feedback affect cortisol?
|
Occurs when cortisol blood levels exceed those produced by usual physiological amounts (cortisol production decreases)
|
|
What is stress feedback in r/t cortisol?
|
When the body is stressed this results in an increase in cortisol production
|
|
What are the indications for corticosteroids in patients experiencing adrenal insufficiency?
|
1. Adrenal crisis
2. Addisonian crisis --> replacement of corticosteroids |
|
What formulations are corticosteroids available as?
|
1. Oral (100% absorption)
2. IV (succinate) 3. IM (acetate) |
|
Which form of corticosteroids should NOT be used for patients in crisis?
|
IM (acetate) -- formulated to work over time
|
|
Which corticosteroid has no mineralcorticoid effect?
|
Dexamethasone
|
|
What is the MOA of mitotane (Lysodren)?
|
1. Blocks cortisol synthesis through inhibition of 11-beta-hydroxylation
2. Destroys functional adrenal tissue |
|
What are the adverse effects of mitotane?
|
Abdominal discomfort; lethargy
|
|
What is the MOA of ketoconazole and etomidate?
|
Inhibits enzymes that produce cortisol
|
|
What is the therapeutic effect of ketoconazole and etomidate?
|
Controls cortisol production -- steroid replacement is not necessary (adrenal tissue remains functional)
|
|
What are the adverse effects of ketoconazole?
|
Gynecomastia; abdominal discomfort; reversible hepatic transaminase elevations
|